Inside Precision Medicine February 24, 2025
Jonathan D. Grinstein, PhD

Unraveling the genetic underpinnings of depression could pave the way for more effective treatments, and a groundbreaking study has now identified 287 genetic risk loci linked to the disorder—49 of them newly discovered. In one of the most extensive cross-ancestry genetic studies on depression, analyzing genetic data from over 1.7 million individuals across diverse ancestries, researchers pinpointed key variants that may influence depression by altering gene regulation and transcription factor binding. This large-scale genetic study, published in Nature Human Behaviour, not only deepens our understanding of depression’s molecular mechanisms but also highlights promising targets for future drug development.

A comprehensive cross-ancestry meta-analysis

Prior genome-wide association studies (GWAS) have identified genetic risk factors for depression; however, a significant portion of the...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Pharma / Biotech, Precision Medicine
23andMe bankruptcy: With America's DNA put on sale, market panic gets a new twist
DispatchHealth and Medically Home merge, Updates on Marathon Health, 23andMe’s Bankruptcy and more Healthcare news this week
InnovationRx: Fatal Drug Overdoses Are Falling – But Medicaid Cuts Could Halt Progress
Shared your DNA with 23andMe? Experts say it's time to delete it
23andMe’s Bankruptcy: What Happens To Your DNA Data When A Genetic Testing Giant Fails?

Share This Article